drugset / Trial / NCT02070471

Phase 2 Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients

NCT02070471 ↗

Phase 2 Completed 60 enrolled LG Life Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

Evaluate the efficacy, Safety and Pharmacokinetics of Intravenous single injection LC28-0126 immediately before PCI (Percutaneous Coronary Intervention) in Patients with STEMI (ST-segment Elevation Myocardial Infarction)

Timeline

Start
2014-01
Primary completion
2015-06
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject LC28-0126 Unknown — Intravenous